An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab-Reference-Cited by-同舟云学术

An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab

Published:2014-09-03 Issue:4 Volume:29 Page:777-782
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Amber K.T.¹,Hertl M.²

Affiliation:

1. Department of Dermatology and Cutaneous Surgery; University of Miami Miller School of Medicine; Miami FL USA

2. Department of Dermatology and Allergology; Philipps-Universität; Marburg Germany

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.12678/fullpdf

Reference36 articles.

1. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris;Chams-Davatchi;J Am Acad Dermatol,2007

2. Rituximab in the Treatment of Pemphigus Vulgaris;Zakka;Dermatol Ther (Heidelb),2012

3. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin;Ahmed;N Engl J Med,2006

4. A single cycle of rituximab for the treatment of severe pemphigus;Joly;N Engl J Med,2007

5. Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients;Kim;Br J Dermatol,2011

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

2. Pemphigus Vulgaris;European Handbook of Dermatological Treatments;2023

3. Pemphigus for the Inpatient Dermatologist;Current Dermatology Reports;2022-09-02

4. Pemphigus vulgaris with refractory gingival ulcerations, successfully treated with rituximab—A case report;Clinical Case Reports;2022-09

5. Long‐term efficacy and safety analysis of single cycle of biosimilar rituximab in pemphigus: A retrospective study of 76 patients from India;Dermatologic Therapy;2022-07-26